Selection Of Local Anesthetics

Front 1

REASONS FOR SELECTING DIFFERENT ANESTHETICS

Back 1

1. DURATION OF PROCEDURE
2. PATIENT HEALTH STATUS
3. HISTORY OF SENSITIVITY OR ALLERGIC REACTION

Front 2

AMIDE LOCAL ANESTHESIA W/ MAXIMUM DOSE OF 6.6mg/kg

Back 2

1. LIDOCAINES HYDROCHLORIDE
2. MEPIVACINE HYDROCHLORIDE

Front 3

LOCAL ANESTHETICS WHICH IS AVOIDED CAUSE BISULFITE ALLERGY OCCUR SINCE THEY HAVE EPINEPHRINE

Back 3

1. LIDOCAINE HYDROCHLORIDE
2. BUPIVACAINE HYDROCHLORIDE
3. ETIDOCAINE HYDROCHLORIDE
4. PRILOCAINE HYDROCHLORIDE

Front 4

LOCAL ANESTHETICS WHICH DURATION OF ACTION IS INTERMEDIATE

Back 4

1. LIDOCAINE
2. MEPIVACAINE
3. PRILOCAINE
4. PROCAINE PLUS PROPOXYCAINE HYDROCHLORIDE
5. ARTICAINE

Front 5

LOCAL ANESTHETICS WHICH HAVE SHORT DURATION BUT CAN BE MADE INTERMEDIATE

Back 5

1. PRILOCAINE
2. PROCAINE+PROPOXYCAINE
3. MEPIVACAINE

Front 6

LOCAL ANESTHETICS WHICH HAVE EPINEPHRINE AS VASOCONTRICTOR

Back 6

1. LIDOCAINE
2. BUPIVACAINE
3. ETIDOCAINE
4. ARTICAINE
5. PRILOCAINE

Front 7

LOCAL ANESTHETICS WHICH HAVE LEVONORDEFRIN AS VASOCONSTRICTOR

Back 7

1. MEPIVACAINE
2. PROCAINE+PROPOXYCAINE

Front 8

AN ESTER LOCAL ANESTHETIC

Back 8

1. PROCAINE+PROPOXYCAINE

Front 9

LOCAL ANESTHETICS W/ LONG DURATION OF ACTION

Back 9

1. ETIDOCAINE
2. BUPIVACAINE

Front 10

A LOCAL ANESTHETIC WHICH LOWER DOSE OF EPINEPHRINE USED CAUSE PATIENT HAVE SIGNIFICANT HEART FAILURE

Back 10

1. LIDOCAINE

Front 11

LIDOCAINE IS ASSOCIATED W/

Back 11

1. DENTAL CARTRIDGE AVAILABLE AS 2% CONCENTRATION W/ 1:100,000 OR 1:50,000 EPINEPHRINE
2. USE LOWER EPINEPHRINE CONC AT LOWER DOSES IN PATIENT W/ SIGNIFICANT HEART FAILURE
3. NON-DENTAL VIALS NO EPINEPHRINE IS AVAILABLE

Front 12

BUPIVACAINE IS ASSOCIATED W/

Back 12

1. 0.5%+ 1:200,00 EPI
2. PROFOUND POST-OP ANALGESIA IN PATIENT WHERE IT IS NOT CONTRAINDICATED
3. CONTRAINDICATED IN PATIENT FOR WHOM PROLONG EFFECT IS HARMFUL(MENTALLY CHALLENGED)
4. MAX DOSE IS 1.3 mg/ kg

Front 13

LONG DURATION ACTION OF BUPIVACAINE HAVE RISK OF

Back 13

1. CARDIAC TOXICITY
2. ARRHYTHMIAS IN HIGHER DOSES

Front 14

ETIDOCAINE IS ASSOCIATED W/

Back 14

1. 1.5 % +EPI 1:200,000
2. USEFUL FOR PROCEDURES WHERE LONGER ANESTHESIA IS NEEDED
3. AVOID WHERE PROLONG ANESTHESIA IS CONTRAINDICATED
4. MAX DOSE IS 8mg/kg

Front 15

ARTICAINE IS ASSOCIATED W/

Back 15

1. 4% +EPI 1:100,000
2. 4X TISSUES AND NERVE INJURY COMPARED TO LIDOCAINE
3. CONTRAINDICATED IN SULFUR ALLERGY AND METHEMOGLOBINEMIA
4. MAX DOSE IS 7mg/kg

Front 16

ANESTHETIC MARKETED AS WHAT YOU NEED TO GET SURE ANESTHESIA

Back 16

1. ARTICAINE

Front 17

ANESTHETIC MECHANISM OF ACTIVE VERY SIMILAR TO LIDOCAINE BUT DOUBLE THE CONC PER ML

Back 17

1. ARTICAINE

Front 18

MEPIVACAINE IS ASSOCIATED W/

Back 18

1. 3% W/ NO VASOCONSTRICTOR
2. 2% W/ 1:200,00 EPI
3. NON-VASOCONTRICTOR PREPARATION MIGHT BE ADVANTAGEOUS IN SEVERE HEART FAILURE PATIENT
4. MORE ALPHA THAN BETA

Front 19

WHEN IS MEPIVACAINE SHORT DURATION MADE INTERMEDIATE

Back 19

1. IF USED W/ LEVONORDEPHRIN

Front 20

LEVONORDEPHRIN HAS LESSER ALPHA 1 AND BETA 1 EFFECTS IT'S BETTER FOR PATIENTS WHERE

Back 20

1. INCREASE IN BLOOD PRESSURE AND HR IS DETRIMENTAL

Front 21

PRILOCAINE IS ASSOCIATED W/

Back 21

1. 4% PLAIN AND 4% W/ 1:200,000 EPI
2. 40% LESS TOXIC THAN LIDOCAINE
3. MAX DOSE IS 6mg/kg
4. EPI PREP CONTRAINDICATED IN BISULFITE ALLERGIES

Front 22

PRILOCAINE SHORT DURATION OF ACTION MADE INTERMEDIATED BY

Back 22

1. ADDING EPI

Front 23

PROCAINE + PROPOXYCAINE ARE ASSOCIATED W/

Back 23

1. 2% PROCAINE +4% PROPOXYCAINE W/ 1:20,000 LEVONORDEFRIN
2. CONTRAINDICATED IN PATIENT W/ METHEMOGLOBINEMIA
3. METABOLIZED PRIMARILY VIA HYDROLYSIS, USEFUL IN LIVER DYSFUNCTION
4. MAX DOSE IS 4.4 mg/ kg

Front 24

FIRST LOCAL ANESTTHETIC AVAILABLE FOR DENTAL USE AND WAS CALLED NOVOCAINE

Back 24

1. PROCAINE ALONE

Front 25

PROCAINE+PROPOXYCAINE VERY SHORT DURATION MADE INTERMEDIATE BY

Back 25

1. ADDING PROPOXYCAINE
AND LOVONORDAFRIN

Front 26

TRUE OR FALSE: ALL LOCAL ANESTHETICS ARE CONTRAINDICATED IF THERE ARE ALLERGIES

Back 26

1. TRUE

Front 27

TRUE OR FALSE: AMIDES ARE TO BE REDUCED OR AVOIDED IN SIGNIFICANT LIVER DYSFUNCTION DUE TO METABOLISM CONCERN

Back 27

1. TRUE

Front 28

ANESTHETIC AVOIDED IN METHEMOGLOBENEMIA

Back 28

1. ARTICAINE (AMIDE)
2. PROCAINE +PROPOXYCAINE (ESTER)

Front 29

RECOMMENDED MAX DOSE FOR EPI FOR SIGNIFICANT CARDIAC DYSFUNCTION

Back 29

1. 0.2 mg
2. 0.04 mg

Front 30

USUAL MAX DOSE FOR LEVONORDEFRIN IS

Back 30

1. 1 mg

Front 31

ELIMINATING VASOCONSTRICTOR WILL LEAD TO APPROX

Back 31

1. 50% REDUCTION IN MAX DOSE

Front 32

NYHA HEART FAILURE CLASSIFICATION

Back 32

1. CLASS I (MILD)
2. CLASS II (MILD)
3. CLASS III (MODERATE)
4. CLASS IV (SEVERE)

Front 33

NO LIMITATION OF PHYSICAL ACTIVITY ORDINARY PHYSICAL ACTIVITY DOES NOT CAUSE UNDUE FATIGUE, PALPITATION, OR DYSPNEA(SHORTNESS OF BREATH)

Back 33

1. CLASS I OF NYHA HF CLASSIFICATION

Front 34

SLIGHT LIMITATION OF PHYSICAL ACTIVITY, COMFORTABLE AT REST, BUT ORDINARY PHYSICAL ACTIVITY RESULT IN FATIGUE, PALPITATION, OR DYSPNEA

Back 34

1. CLASS II

Front 35

LIMITATION OF PHYSICAL ACTIVITY, COMFORTABLE AT REST, BUT LESS THAN ORDINARY ACTIVITY CAUSES FATIGUE, PALPITATION, OR DYSPNEA

Back 35

1. CLASS III

Front 36

UNABLE TO CARY OUT ANY PHYSICAL ACTIVITY W/O DISCOMFORT, SYMPTOMS OF CARDIAC INSUFFICIENCY AT REST, IF ANY PHYSICAL ACTIVITY IS UNDERTAKEN, DISCOMFORT IS INCREASE

Back 36

1. CLASS IV

Front 37

FUNDAMENTAL ABOUT GIVING LOCAL ANESTHETICS

Back 37

1. ACCURATE MEDICAL AND ALLERGY HISTORY
2. ORGANIZED TREATMENT PLAN
3. VITAL SIGNS AT INITIAL APPOINTMENT AND PRE-OPERATIVE
4. USS A PER kg MAX DOSAGE RATHER THAN NUMBER OF CARPULES